Novartis AG
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Novartis AG generated cash of $14,458,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$14,278,000,000 last year. Net change in cash is therefore $5,876,000,000.
Cash Flow
| 2014 | 13.89B | 881M | -8.14B |
|---|---|---|---|
| 2015 | 11.89B | -10.78B | -9.17B |
| 2016 | 11.47B | -3.44B | -5.31B |
| 2017 | 12.62B | -3.11B | -7.73B |
| 2018 | 14.27B | -5.59B | -4.24B |
| 2019 | 13.62B | -2.22B | -13.62B |
| 2020 | 13.65B | -13.18B | -2.20B |
| 2021 | 15.07B | 4.20B | -16.26B |
| 2022 | 14.23B | 1.46B | -20.56B |
| 2023 | 14.45B | 5.59B | -14.27B |
NOVN.SW Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 7.51B | 12.40B | 9.65B | 11.11B | 13.27B | 8.86B | 7.00B | 4.67B | 13.02B | 6.68B |
Operating activities | ||||||||||
Net income | 8.57B | 6.95B | 24.01B | 8.07B | 7.14B | 12.61B | 7.70B | 6.69B | 7.02B | 10.72B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 8.27B | 7.18B | 6.11B | 6.46B | 5.82B | 6.89B | 6.07B | 6.04B | 5.57B | 4.75B |
Stock-based compensation expense | 865M | 791M | 700M | 738M | 758M | 759M | 683M | 671M | 773M | 744M |
| Deferred income tax benefit | 865M | 791M | 700M | 738M | 758M | 759M | 683M | 671M | 773M | 744M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.50B | -589M | -389M | 137M | -980M | -569M | -204M | -229M | -513M | -367M |
Inventories | -546M | -830M | 81M | -543M | -382M | -533M | -247M | -235M | -482M | -506M |
Accounts payable | 479M | -48M | -21M | -324M | 553M | 309M | 58M | -587M | 378M | 142M |
Cash generated by operating activities | 14.45B | 14.23B | 15.07B | 13.65B | 13.62B | 14.27B | 12.62B | 11.47B | 11.89B | 13.89B |
Investing activities | ||||||||||
Purchases Of Investments | -747M | -34.81B | -16.59B | -2.13B | -530M | -2.70B | -1.04B | -777M | -859M | -408M |
Investments In Property Plant And Equipment | -1.06B | -2.67B | -2.97B | -2.58B | -2.25B | -3.35B | -2.74B | -2.87B | -3.85B | -3.70B |
Acquisitions Net | -3.56B | -903M | 20.10B | -9.96B | -3.76B | -1.06B | -755M | -765M | -16.50B | -331M |
Cash generated by investing activities | 5.59B | 1.46B | 4.20B | -13.18B | -2.22B | -5.59B | -3.11B | -3.44B | -10.78B | 881M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 10.08B | 1.96B | 5.23B | 0 | 3.96B | 0 | 5.91B |
Payments for dividends | -7.25B | -7.50B | -7.36B | -6.98B | -6.64B | -6.96B | -6.49B | -6.47B | -6.64B | -6.81B |
Repurchases of common stock | -8.71B | -10.65B | -3.05B | -2.84B | -5.53B | -2.03B | -5.49B | -1.10B | -6.07B | -4.51B |
Repayments of term debt | -1.93B | -2.58B | -2.44B | -2.31B | 0 | -366M | 4.10B | -1.69B | 1.96B | -2.59B |
Cash used in financing activities | -14.27B | -20.56B | -16.26B | -2.20B | -13.62B | -4.24B | -7.73B | -5.31B | -9.17B | -8.14B |
Net Change In Cash | 5.87B | -4.89B | 2.74B | -1.45B | -2.15B | 4.41B | 1.85B | 2.33B | -8.34B | 6.33B |
Cash at end of period | 13.39B | 7.51B | 12.40B | 9.65B | 11.11B | 13.27B | 8.86B | 7.00B | 4.67B | 13.02B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |